SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL CO., LTD. DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

Related Companies

Affiliated to Shanghai Pharma, Shanghai Zhongxi Sunve Pharmaceutical Co., Ltd. was set up through powerful coalition of former Shanghai Zhongxi Pharmaceutical Co., Ltd., which was renowned for a century-long history, and Shanghai Sunve Pharmaceutical Co., Ltd., a large-scale pharmaceutical enterprise in China and operates as a designated enterprise by Shanghai Pharma to be engaged in the development of the characteristic raw m...

Affiliated to Shanghai Pharma, Shanghai Zhongxi Sunve Pharmaceutical Co., Ltd. was set up through powerful coalition of former Shanghai Zhongxi Pharmaceutical Co., Ltd., which was renowned for a century-long history, and Shanghai Sunve Pharmaceutical Co., Ltd., a large-scale pharmaceutical enterprise in China and operates as a designated enterprise by Shanghai Pharma to be engaged in the development of the characteristic raw material drugs and supportive preparations. The Company runs the Taopu production base and Xinghuo production base of raw material drugs. The shareholding enterprises include Shanghai Zhongxi Pharmaceutical Co., Ltd., Shanghai Sunve Baoling Pharmaceutical Plant, Shanghai Jinhe Bio-Tech Co., Ltd. and Shipu Pharmaceutical Chemical Plant, with Changzhou Kangli Pharmaceutical Co., Ltd. under its management as delegated. The Company boasts to have the profound historical legacy and keeps updating and broadening its product lines and perfecting product structures subject to the premises of both the market demands and qualities. The Company runs such product lines as the raw material drugs, preparations and medical intermedia etc., while mainly focusing on such areas as the anti-rheumatic area, metal and nervous area and oncology and holding a number of the unique types and preparations. The key raw material drugs that are currently produced by the Company include Hydroxychloroquine Sulfate, Sulfasalazine, Pyridostigmine Bromide, Ursodeoxycholic Acid; the key preparation types include Danxiangguanxin Zhusheye, Hydroxychloroquine Sulfate Tablets, Aripiprazole Tablets, Duloxetine Hydrochloride Tablets, Zopiclone etc. Part of the raw material drugs have been certified by FDA and successfully registered by the EDMF document. The raw material drugs are sold extensively both at home and abroad. The Company boasts to have the sound technical capacities and has been awarded the honorary title of a hi-tech enterprise of Shanghai. The Company’s Technical Center was selected to be one of the corporate technical centers of Shanghai. The Company’s raw material drugs not only satisfy the domestic market demands, but also are sold to the overseas markets. Relying on its own terminal force, the Company has attained breakthrough achievements in terms of the preparation products, and especially the new drug products, which enjoy remarkable popularities in the respective areas.

Company profile for SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL CO., LTD.

SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL CO LTD

SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL CO LTD

About

Contact Details

EVENTS

Webinars & Exhibitions

PRESENTATION(s)

VIDEO(s)

DIGITAL CONTENT

APIs // Active Pharmaceutical Ingredients

3 APIs

3 USDMF

4 KDMF

DEVELOPMENTS

INSPECTIONS & REGISTRATIONS

1 FDA

What are you looking for?